FdaApplication
ANDA 219865
Identifiers
- fda_app_no: ANDA219865
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT VI |
| application_type | ANDA |
| approval_date | 2026-04-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHOTREXATE SODIUM | METHOTREXATE SODIUM | EQ 50MG BASE/2ML (EQ 25MG BASE/ML) | INJECTABLE;INJECTION |
1 product